Hospital Necker - Enfants Malades
Paris, 75015, France
NCT Number: NCT02296944
This study is a retrospective cohort of patients minors during the operation of cartilage tympanoplasty for tympanic membrane perforation
Looking for future studies?
Notify Me3 year–35 year
All sexes
Observational
Paris, 75015, France
The investigators hypothesis is that the cartilage tympanoplastie lead to a closure of the tympanic membrane in 95% of cases. But the investigators believe that certain risk factors may influence the anatomical and functional results of tympanoplastie of the child and that their inclusion could improve these results.
For example, young age is not clear so far as a potential risk factor in the few studies analyzing this factor independently. A recommendation of the French Society of ENT surgery tympanic membrane perforation of the Child in 2006 recommended a minimum age of 6 years. However, the level of evidence of articles analyzed was small (it was basically a consensus of experts) and the investigators feel it necessary to study this factor by age (<7 years, 7-10 years, 11-14 years ,> 14 years) on a large cohort to determine the real influence of age on the anatomical and functional results as this may lead to changes in practice.
Similarly, whatever the influence of age in the general population, it could be a key criterion in children who have a particular field leading to prolonged tubal dysfunction (vélopalatines slots and craniofacial malformations), leading to raising the age of surgery tympanic closure: the investigators have for example in 1000 tympanoplasties for perforation, expected recruitment numbers in this study, 50 patients with craniofacial malformation or vélopalatine slot.
The purpose of this study is to investigate the factors influencing the anatomic outcome at one year of cartilage tympanoplastie child.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 12 months (range 9 to 18 months)
Time frame: 12 months (range 9 to 18 months)
Time frame: 36 months ( range 30 to 42 months)
Time frame: 36 months ( range 30 to 42 months)
Time frame: 36 months ( range 30 to 42 months)
Assistance Publique - Hôpitaux de Paris
Other
Acronym: PERFOPED
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07698171
Ear Diseases, Myringoplasty
Holon, Israel
View Trial DetailsNCT07535827
Ear Diseases, Glucose Metabolism Disorders
Minya, Egypt
View Trial DetailsNCT07595484
Chronic Otitis Media, Ear Diseases
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT06083181
Ear Diseases, Otorhinolaryngologic Diseases
Los Angeles, California, United States
View Trial Details